Frenemies: New Collaboration Models - Healthy Returns

Once-fierce competitors are now collaborating on vaccine discovery, while also working to keep their exclusive pipelines primed. Is this a model that will outlast the crisis? We'll take a deep dive into pharma R&D, for coronavirus and beyond. GSK's Hal Barron and Sanofi's John Reed speak to Meg Tirrell at Healthy Returns.
Thu, May 14 20207:42 PM EDT